🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity ◆ Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing ◆ Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich ◆ Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery ◆ Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma ◆ Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide ◆ The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany ◆ Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact ◆ Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity ◆ Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing ◆ Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich ◆ Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery ◆ Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma ◆ Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide ◆ The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany ◆ Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact ◆
Clinical Trials in Spain / NCT07007013
Active, not recruiting Not applicable

Impact of Humor Prescription on the Emotional Well-being of Patients With Medically Unexplained Symptoms: A Quasi-experimental Study

NCT07007013 · tracked via the Priya Life Science Spain tracker
Phase
Not applicable
Started
2025-09-01
Last updated
2025-12-05

Condition(s) studied

Medically Unexplained Symptoms

Investigational drug(s) / intervention(s)

Humor therapy

Humor therapy: The intervention consists of a cycle of 8 group sessions (one per week) led by trained professionals specialized in humor ('clown doctors'). Each session will last approximately 90 to 120 minutes

Study summary

This study aims to study the effectiveness of the intervention for medically unexplained symptoms(MUS) in terms of changes in emotional well-being before and after the intervention (humor therapy)

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Participants may be included in the trial if they meet all of the following inclusion criteria: * Men and women over 18 years of age. * Diagnosed with the condition under study (see Section 2: Definitions). * Expected to undergo follow-up for their condition at the study center. * Ability to participate in the required assessments. * Legal capacity to provide informed consent. * Signed informed consent for inclusion in the study, either by the participant or their legal representative. Exclusion Criteria: * Participants will be excluded if they meet any of the following exclusion criteria: * Participants diagnosed with any of the following conditions: * Severe mental health disorder, as determined by the investigator * Cognitive impairment of any etiology, as recorded in the medical history * Treatment for the condition under study using community-based resources prescribed in Primary Care within the past 6 months. * Cognitive or affective disorders that limit the ability to comply with study procedures. * Participation in another study involving an experimental intervention during the period of the present trial and/or requiring visit schedules that are incompatible with this trial.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
CAPI Baix A Mar (CSAPG) Vilanova i la Geltrú Barcelona

More Consorci Sanitari de l'Alt Penedès i Garraf trials in Spain

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07007013 on ClinicalTrials.gov ↗ ← All trials in Spain